Identification of a Missense Mutation in the α-galactosidase A Gene in a Chinese Family with Fabry Disease
Open Access
- 1 December 2017
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Genomics
- Vol. 19 (1) , 70-75
Abstract
Introduction: Fabry Disease (FD), the second most common lysosomal storage disorder after Gaucher disease, is characterized by variable clinical manifestations, including angiokeratoma, corneal dystrophy, recurrent episodes of extremity pain, renal impairment, cardiac complications and cerebrovascular manifestations. It is caused by mutations in the α-galactosidase A gene (gene symbol GLA) on chromosome Xq22, which leads to deficiency of lysosomal α-galactosidase A (α-Gal A), and subsequent accumulation of glycosphingolipids in various tissues and organs. The aim of this study is to identify the disease-causing mutation in a five-generation Chinese family with FD. A c.782G>T transversion (p.G261V) in the GLA gene was identified in four patients and two asymptomatic carriers by direct sequencing, and it co-segregated with the disease in the family. The variant is predicted to be disease-causing mutation and result in seriously abnormal function of α-Gal A. Four patients in this family present with classic phenotype of FD, including acroparesthesias, hypohidrosis, angiokeratomas and intermittent burning pain in extremity. Conclusion: The disease severity is similar among male and female patients. Our study extends the genotype-phenotype relationship between mutations in the GLA gene and clinical findings of FD, which may be helpful in the genetic counseling of patients with FD.Keywords
This publication has 38 references indexed in Scilit:
- A family with various symptomatology suggestive of Anderson–Fabry disease and a genetic polymorphism of alpha galactosidase A geneClinical Biochemistry, 2015
- Identification of a novel COL4A5 mutation in a Chinese family with X-linked Alport syndrome using exome sequencingMolecular Biology Reports, 2014
- Fabry disease: experience of screening dialysis patients for Fabry diseaseClinical and Experimental Nephrology, 2013
- A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significanceJournal of Medical Genetics, 2013
- Gene Therapy for Fabry Disease: A Review of the LiteratureBioDrugs, 2013
- Fabry DiseaseDeutsches Ärzteblatt international, 2009
- Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry RegistryJournal of Inherited Metabolic Disease, 2007
- Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome SurveyEuropean Journal of Clinical Investigation, 2004
- The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapyClinical Genetics, 2004
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier femalesJournal of Medical Genetics, 2001